Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology

Joseph Therriault; Nicholas J. Ashton; Ilaria Pola; Gallen Triana‐Baltzer; Wagner S. Brum; Guglielmo Di Molfetta; Burak Arslan; Nesrine Rahmouni; Cécile Tissot; Stijn Servaes; Jenna Stevenson; Arthur C. Macedo; Tharick A. Pascoal; Hartmuth C. Kolb; Andreas Jeromin; Kaj Blennow; Henrik Zetterberg; Pedro Rosa‐Neto; Andréa Lessa Benedet

doi:10.1016/j.ebiom.2024.105046

Abstract

This is the authors' abstract. We don't add key points for this paper.

This research is supported by the Weston Brain Institute, Canadian Institutes of Health Research (CIHR), Canadian Consortium on Neurodegeneration in Aging, the Alzheimer's Association, Brain Canada Foundation, the Fonds de Recherche du Québec - Santé and the Colin J. Adair Charitable Foundation.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Therriault et al. (2024) studied this question.

synapsesocial.com/papers/69dcc732a5c75be4cfe5423d https://doi.org/10.1016/j.ebiom.2024.105046

View Full Paper

Ask AI

Bookmark

Share

Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology

Abstract

Ask about this paper

Discussion

Cite This Study

Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading